Similar users

Faten RIDENE

Faten RIDENE

Didactics,  Film Studies,  Cultural Heritage,  Freedom Of Expression,  Censorship,  Performing Arts,  Cinema And Television
12 publications
Torsten Oettinger

Torsten Oettinger

Psychiatry & Psychology,  Philosophy And Religious Stuidies Information
8 publications
Nia Cason

Nia Cason

Cognition,  Writer Editor,  Neuroscience & Psychology,  Freelance,  Journaliste Scientifique
Marshall Hubsher

Marshall Hubsher

Psychiatry,  Mental Health,  Mental Disorders
25 publications
Aliona Nastas
Andrea de Bartolomeis

Andrea de Bartolomeis

Full Professor of Health Technology Applied t oMedical Science and Director of The Clinical Section of Psychiatry and Psychology University of Naples Federico II

Disciplines: Pharmacology Neuroscience & Behavior Psychiatry/Psychology
Napoli, Italy

Summary

Andrea de Bartolomeis MD, Ph.D. is a Full Professor of Health, Director of the Section of Psychiatry and Chief of the Laboratory of Molecular Psychiatry at the Department of Neuroscience, University School of Medicine of Napoli Federico II, and Director of the Residency Program in Psychiatry Andrea de Bartolomeis received his medical degree and his residency training in psychiatry at the University of Naples Federico II, Italy. He completed his postdoctoral training as the recipient of a Fogarty Fellowship in psychopharmacology and molecular pathophysiology of schizophrenia with NIMH in Bethesda MD (USA) first at Clinical Neuroscience Branch (1989-1992) and then at the Experimental Therapeutics Branch (1993-1995) where he contributed to developing a novel method for the quantitation of synaptic dopamine in vivo in primates, using PET and microdialysis simultaneously. This method was instrumental for the first demonstration in vivo by PET and 11C-raclopride of the enhanced release of dopamine after amphetamine challenge in the striatum of schizophrenic patients compared to normal controls. He has been Visiting scientist at the Neuroendocrinology Branch of NIMH, Bethesda, MD, USA, and a Guest scientist at NIMH ETB and Anxiety Mood Disorder Program in several occasions from 1995 to 2000, for collaborating project In 1998 he received from the University of Naples a Ph.D. degree in Methodology of Communication Science. He is the Chief of the Outpatient Clinics for Treatment-Resistant Psychosis. and coordinator of the Consultation Psychiatry and Psychotherapy section at the Department of Neuroscience and Behavior, University of Naples Federico II. The research interest of Andrea de Bartolomeis includes the molecular pathophysiology of psychosis, CNS gene expression modulation by psychotropic drugs, and augmentation strategy in psychosis pharmacotherapy. He has been the principal investigator or co-investigator on several research and training grants as well on clinical trials from public and drug company sources. He is a member of the American Society for Neuroscience, International Society for Schizophrenia Research, New York Academy of Sciences, Italian Society of Neuroscience, Italian Society of Psychopathology, and European Collegium of Neuropsychopharmacology. He has been elected in the board of directors of the Italian Society for Neuroscience for the years 2012-2014. He is member of He has authored articles, book chapters, and published abstracts on molecular mechanisms of antipsychotics as well as on schizophrenia pathophysiology and molecular imaging of dopaminergic system He published his works in: Nature Medicine, Neuron, Proceedings of National Academy of Sciences, Biological Psychiatry, Neuropsychopharmacology, Nature Translational Psychiatry, Molecular Brain Research, Synapse, Cerebral Blood flow and Metabolism, Neuroreport, Current Drug Design, European Neuropsychopharmacology, Annals of New York Academy of Sciences, Neuroscience, Molecular Neurobiology, Psychiatry Research, Journal of Psychiatry Research

Experience

Director Chair of Psychiatry Since November 2013

Università degli Studi di Napoli Federico II (Napoli IT)

Andrea de Bartolomeis MD, Ph.D. is Full Profesor of Health Technology Applied to Medical Science ,Director of the Section of Psychiatry and Chief of the Laboratory of Molecular Psychiatry at the Department of Neuroscience, University School of Medicine of Napoli Federico II and Director of the Residency Program in Psychiatry Andrea de Bartolomeis received his medical degree and his residency training in psychiatry at the University of Naples Federico II, Italy. He completed his postdoctoral training as the recipient of a Fogarty Fellowship in psychopharmacology and molecular pathophysiology of schizophrenia with NIMH in Bethesda MD (USA) first at Clinical Neuroscience Branch (1989-1992) and then at the Experimental Therapeutics Branch (1993-1995) where he contributed to developing a novel method for the quantitation of synaptic dopamine in vivo in primates, using PET and microdialysis simultaneously. This method was instrumental for the first demonstration in vivo by PET and 11C-raclopride of the enhanced release of dopamine after amphetamine challenge in the striatum of schizophrenia patients compared to normal controls. He has been Visiting scientist at the Neuroendocrinology Branch of NIMH, Bethesda, MD, USA, and Guest scientist at NIMH ETB and Anxiety Mood Disorder Program in several occasions from 1995 to 2000, for collaborating on project In 1998 he received from the University of Naples a Ph.D. degree in Methodology of Communication Science. He is the Chief of the Outpatient Clinics for Treatment-Resistant Psychosis. and coordinator of the Consultation Psychiatry and Psychotherapy section at the Department of Neuroscience and Behavior, University of Naples Federico II. The research interest of Andrea de Bartolomeis includes the molecular pathophysiology of psychosis, CNS gene expression modulation by psychotropic drugs, and augmentation strategy in psychosis pharmacotherapy. He has been the principal investigator or co-investigator on several research and training grants as well on clinical trials from public and drug company sources. He is a member of the American Society for Neuroscience, International Society for Schizophrenia Research, New York Academy of Sciences, Italian Society of Neuroscience, Italian Society of Psychopathology, and European Collegium of Neuropsychopharmacology. He has been elected to the board of directors of the Italian Society for Neuroscience for the years 2012-2014. He is member of He has authored articles, book chapters, and published abstracts on molecular mechanisms of antipsychotics as well as on schizophrenia pathophysiology and molecular imaging of the dopaminergic system He published his works in Nature Medicine, Neuron, Proceedings of National Academy of Sciences, Biological Psychiatry, Neuropsychopharmacology, Nature Translational Psychiatry, Molecular Brain Research, Synapse, Cerebral Blood flow, and Metabolism, Neuroreport, Current Drug Design, European Neuropsychopharmacology, Annals of New York Academy of Sciences, Neuroscience, Molecular Neurobiology, Psychiatry Research, Journal of Psychiatry Research

Education

MD PhD October 1978 - July 1997

Università degli Studi di Napoli Federico II (Napoli IT)

Andrea de Bartolomeis MD, Ph.D. is Full Professor of Health Technology Applied to Medical Science , Director of the Section of Psychiatry and Chief of the Laboratory of Molecular Psychiatry at the Department of Neuroscience, University School of Medicine of Napoli Federico II and Director of the Residency Program in Psychiatry Andrea de Bartolomeis received his medical degree and his residency training in psychiatry at the University of Naples Federico II, Italy. He completed his postdoctoral training as the recipient of Fogarty Fellowship in psychopharmacology and molecular pathophysiology of schizophrenia with NIMH in Bethesda MD (USA) first at Clinical Neuroscience Branch (1989-1992) and then at the Experimental Therapeutics Branch (1993-1995) where he contributed to developing a novel method for the quantitation of synaptic dopamine in vivo in primates, using PET and microdialysis simultaneously. This method was instrumental for the first demonstration in vivo by PET and 11C-raclopride of the enhanced release of dopamine after amphetamine challenge in the striatum of schizophrenia patients compared to normal controls. He has been Visiting scientist at the Neuroendocrinology Branch of NIMH, Bethesda, MD, USA, and a Guest scientist at NIMH ETB and Anxiety Mood Disorder Program in several occasions from 1995 to 2000, for collaborating projects In 1998 he received from the University of Naples a Ph.D. degree in Methodology of Communication Science. He is the Chief of the Outpatient Clinics for Treatment-Resistant Psychosis. and coordinator of the Consultation Psychiatry and Psychotherapy section at the Department of Neuroscience and Behavior, University of Naples Federico II. The research interest of Andrea de Bartolomeis includes the molecular pathophysiology of psychosis, CNS gene expression modulation by psychotropic drugs, and augmentation strategy in psychosis pharmacotherapy. He has been the principal investigator or co-investigator on several research and training grants as well on clinical trials from public and drug company sources. He is a member of the American Society for Neuroscience, International Society for Schizophrenia Research, New York Academy of Sciences, Italian Society of Neuroscience, Italian Society of Psychopathology, and European Collegium of Neuropsychopharmacology. He has been elected in the board of directors of the Italian Society for Neuroscience for the years 2012-2014. He is member of He has authored articles, book chapters, and published abstracts on molecular mechanisms of antipsychotics as well as on schizophrenia pathophysiology and molecular imaging of the dopaminergic system He published his works in: Nature Medicine, Neuron, Proceedings of National Academy of Sciences, Biological Psychiatry, Neuropsychopharmacology, Nature Translational Psychiatry, Molecular Brain Research, Synapse, Cerebral Blood flow, and Metabolism, Neuroreport, Current Drug Design, European Neuropsychopharmacology, Annals of New York Academy of Sciences, Neuroscience, Molecular Neurobiology, Psychiatry Research, Journal of Psychiatry Resarch

Contact me

Report this profile